NEWSpublisher 2007 :: AngloChinese Investments
SEARCH NEWS
date from:
date to:
company:
search for string:
NEWS SECTIONS
COMPANY GROUPS
TOP NEWS
» 23/07/2009 [Company watch]
China Aoxing Pharmaceutical Corp. Receives Renewal of GMP Certification for Capsule Dosage Form of Pharmaceutical Products
» 15/03/2010 [Industry news]
Recordati S.p.A And Lee Pharmaceutical Announce Partnership For Zanidip(R) In China
» 26/10/2009 [Finance]
China Growth to Remain Fast in Fourth Quarter, Official Says
» 17/08/2009 [Industry news]
Chindex Posts Profit on Product Sales, Health Services
» 07/05/2010 [Industry news]
Hong Kong: Recall of all products manufactured by Quality Pharmaceutical Lab Ltd
COMPANY NEWS back to previous page show list
TOP NEWS
»08/04/2010 [Industry news]
MicuRx, Cumencor, Pfizer to discover TB drugs in China

Three companies have come together to discover therapeutic agents to treat multidrug resistant TB in China.

 
Three companies have come together to discover therapeutic agents to treat multidrug resistant TB in China. The companies are MicuRx Pharmaceuticals Cumencor Pharmaceuticals and Pfizer. The former companies have tied up with Pfizer. While Pfizer and MicuRx are based in the US, Cumencor is a Chinese company. A release said Cumencor will apply MicuRx\'s proprietary technology platform to discover and develop novel antibiotics for MDR-TB. MicuRx and Cumencor are both biotechnology companies. As part of the deal, Pfizer will give an upfront payment, funding for the discovery and preclinical development of novel antibiotics to treat MDR-TB, and other milestone payments. All research will be conducted at the ZhangJiang High-Tech Park in Shanghai, China.

AngloChinese Investments ltd.
Home | Company news | TOP 50 | Events | About us
C&F Bright Solutions ltd.